Q3 2024 · 13F-HR
venBio Partners LLCholdings as filed
Filed 2024-11-14 · accession 0000905148-24-003147
$194.3M
Reported value
6
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N69605108 | PHVS | PHARVARIS N V | $79.4M | 40.9% | 4,289,304 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $30.2M | 15.5% | 2,826,048 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $24.6M | 12.7% | 614,594 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $23.5M | 12.1% | 1,519,971 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $19.0M | 9.77% | 3,852,470 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $17.7M | 9.08% | 9,699,925 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.